-
1
المؤلفون: Alfonso Tafur, Eduardo Ramacciotti, Jawed Fareed, Fabio Lievano, Grigoris T. Gerotziafas, Omer Iqbal, Charles A. Carter, Joseph Lewis, Meharvan Singh, Jeanine M. Walenga, Bruce E. Lewis, Walter Jeske, Bulent Kantarcioglu
المساهمون: Loyola University [Chicago], Abbvie Inc. [North Chicago], Service d'Hématologie biologique [CHU Tenon], CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
المصدر: Clinical and Applied Thrombosis/Hemostasis
Clinical and Applied Thrombosis/Hemostasis, SAGE Publications, 2021, 27, pp.107602962110214. ⟨10.1177/10760296211021498⟩
Clinical and Applied Thrombosis/Hemostasis, Vol 27 (2021)مصطلحات موضوعية: Male, MESH: Models, Cardiovascular, [SDV]Life Sciences [q-bio], thrombocytopenia, Review, Platelet Factor 4, Pathogenesis, Sinus Thrombosis, Intracranial, 0302 clinical medicine, MESH: Genetic Vectors, MESH: Platelet Factor 4, Pandemic, Global health, Drug approval, MESH: Autoantibodies, MESH: COVID-19, 030212 general & internal medicine, Drug Approval, Glycosaminoglycans, 0303 health sciences, Clinical Trials as Topic, Vaccines, Synthetic, heparin induced thrombocytopenia, Models, Cardiovascular, MESH: Glycosaminoglycans, Hematology, General Medicine, 3. Good health, Vaccination, safety and efficacy, MESH: Sinus Thrombosis, Intracranial, MESH: COVID-19 Vaccines, Female, Safety, MESH: Vaccines, Inactivated, medicine.medical_specialty, MESH: Pandemics, COVID-19 Vaccines, Coronavirus disease 2019 (COVID-19), MESH: Clinical Trials as Topic, MESH: Vaccines, Synthetic, MESH: Disseminated Intravascular Coagulation, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Genetic Vectors, Objective assessment, 03 medical and health sciences, ChAdOx1 nCoV-19, medicine, Diseases of the circulatory (Cardiovascular) system, Humans, MESH: SARS-CoV-2, MESH: Thrombosis, Intensive care medicine, Pandemics, BNT162 Vaccine, thrombosis, 030304 developmental biology, Autoantibodies, MESH: Humans, Ad26COVS1, business.industry, MESH: Drug Approval, SARS-CoV-2, MESH: Safety, COVID-19, Disseminated Intravascular Coagulation, MESH: Male, Vaccines, Inactivated, RC666-701, business, MESH: Female
-
2
المؤلفون: Guillaume Padern, Yves-Marie Pers
المساهمون: Cellules Souches, Plasticité Cellulaire, Médecine Régénératrice et Immunothérapies (IRMB), Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Herrada, Anthony, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)
المصدر: Nature Reviews Rheumatology
Nature Reviews Rheumatology, Nature Publishing Group, 2020, 16 (12), pp.671-672. ⟨10.1038/s41584-020-00521-x⟩
Nature Reviews. Rheumatologyمصطلحات موضوعية: 0301 basic medicine, Time Factors, MESH: Hydroxychloroquine, Azithromycin, Arthritis, Rheumatoid, 0302 clinical medicine, Anti-Infective Agents, Cardiac toxicity, Medicine, MESH: COVID-19, News & Views, [SDV.MHEP.RSOA] Life Sciences [q-bio]/Human health and pathology/Rhumatology and musculoskeletal system, MESH: Arthritis, Rheumatoid, Anti-Bacterial Agents, 3. Good health, [SDV.MHEP.RSOA]Life Sciences [q-bio]/Human health and pathology/Rhumatology and musculoskeletal system, Cardiovascular Diseases, MESH: Heart Disease Risk Factors, Rheumatoid arthritis, Drug Therapy, Combination, Drug therapy, Safety, Hydroxychloroquine, medicine.drug, 2019-20 coronavirus outbreak, medicine.medical_specialty, Coronavirus disease 2019 (COVID-19), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), MESH: Anti-Infective Agents, Antimalarials, 03 medical and health sciences, Rheumatology, Internal medicine, MESH: Anti-Bacterial Agents, MESH: Azithromycin, Humans, MESH: SARS-CoV-2, 030203 arthritis & rheumatology, MESH: Humans, MESH: Sulfasalazine, SARS-CoV-2, business.industry, Adverse effects, MESH: Safety, MESH: Time Factors, COVID-19, MESH: Cardiovascular Diseases, medicine.disease, bacterial infections and mycoses, MESH: Antimalarials, COVID-19 Drug Treatment, Sulfasalazine, MESH: Drug Therapy, Combination, 030104 developmental biology, Heart Disease Risk Factors, business
-
3
المؤلفون: Joubert, Olivier, Kokot, Hana, Kokot, Boštjan, Sebastijanović, Aleksandar, Voss, Carola, Podlipec, Rok, Zawilska, Patrycja, Berthing, Trine, Ballester-López, Carolina, Danielsen, Pernille Høgh, Contini, Claudia, Ivanov, Mikhail, Krišelj, Ana, Čotar, Petra, Zhou, Qiaoxia, Ponti, Jessica, Zhernovkov, Vadim, Schneemilch, Matthew, Doumandji, Zahra, Pušnik, Mojca, Umek, Polona, Pajk, Stane, Schmid, Otmar, Urbančič, Iztok, Irmler, Martin, Beckers, Johannes, Lobaskin, Vladimir, Halappanavar, Sabina, Quirke, Nick, Lyubartsev, Alexander, Vogel, Ulla, Koklič, Tilen, Stoeger, Tobias, Štrancar, Janez, Ballester‐López, Carolina
المساهمون: Institut Jean Lamour (IJL), Université de Lorraine (UL)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS), Commission of the European Communities
المصدر: Advanced Materials
Advanced Materials, Wiley-VCH Verlag, 2020, 32 (47), pp.2003913. ⟨10.1002/adma.202003913⟩
Adv. Mater. 32:e2003913 (2020)مصطلحات موضوعية: MESH: Inflammation, Technology, material safety and health hazards, Chemistry, Multidisciplinary, [SDV]Life Sciences [q-bio], 02 engineering and technology, Advanced materials, 01 natural sciences, 09 Engineering, Epithelium, NANOPARTICLES, General Materials Science, Lung, 02 Physical Sciences, Single exposure, Chemistry, Physical, Physics, HAZARD, advanced microscopies, 021001 nanoscience & nanotechnology, Material development, adverse outcome pathways, 3. Good health, ddc, Chemistry, Physics, Condensed Matter, CHEMICAL SAFETY, Inhalation, MESH: Particulate Matter, Advanced Microscopies, Adverse Outcome Pathways, Disease Prediction, Material Safety And Health Hazards, Mode Of Action, Mechanics of Materials, Lung epithelium, Physical Sciences, Science & Technology - Other Topics, MESH: Inhalation, Safety, medicine.symptom, 03 Chemical Sciences, 0210 nano-technology, NANOTOXICOLOGY, disease prediction, Materials science, In silico, Materials Science, Materials Science, Multidisciplinary, Inflammation, Computational biology, Predictive toxicology, 010402 general chemistry, Physics, Applied, ACTIN, mode of action, MESH: Computer Simulation, Toxicity Tests, medicine, Computer Simulation, MESH: Lung, EXPOSURE, MESH: Particle Size, Nanoscience & Nanotechnology, Particle Size, MESH: Toxicity Tests, NANOMATERIALS, Science & Technology, Mechanical Engineering, MESH: Chronic Disease, MESH: Safety, 0104 chemical sciences, MESH: Epithelium, MOLECULAR-DYNAMICS, Chronic Disease, Particulate Matter, MATTER, RESPONSES
وصف الملف: application/pdf
-
4
المؤلفون: Muriel Golzio, Elisabeth Bellard, Rémy Poupot, Abdelouahd Oukhrib, Séverine Fruchon, Cédric-Olivier Turrin, Nicolas Beton, Muriel Blanzat, Cécile Goursat, Anne-Marie Caminade
المساهمون: Centre de Physiopathologie Toulouse Purpan (CPTP), Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut de pharmacologie et de biologie structurale (IPBS), Université de Toulouse (UT)-Université de Toulouse (UT)-Centre National de la Recherche Scientifique (CNRS), Laboratoire de chimie de coordination (LCC), Institut de Chimie de Toulouse (ICT), Institut de Recherche pour le Développement (IRD)-Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Institut National Polytechnique (Toulouse) (Toulouse INP), Université de Toulouse (UT)-Institut de Recherche pour le Développement (IRD)-Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Centre National de la Recherche Scientifique (CNRS), Interactions moléculaires et réactivité chimique et photochimique (IMRCP), Université de Toulouse (UT)-Institut Ecologie et Environnement (INEE), Centre National de la Recherche Scientifique (CNRS)-Centre National de la Recherche Scientifique (CNRS)-Fédération de Recherche Fluides, Energie, Réacteurs, Matériaux et Transferts (FERMAT), Institut National des Sciences Appliquées - Toulouse (INSA Toulouse), Institut National des Sciences Appliquées (INSA)-Université de Toulouse (UT)-Institut National des Sciences Appliquées (INSA)-Université de Toulouse (UT)-Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Centre National de la Recherche Scientifique (CNRS)-Institut National Polytechnique (Toulouse) (Toulouse INP), Université de Toulouse (UT)-Institut National des Sciences Appliquées - Toulouse (INSA Toulouse), Institut National des Sciences Appliquées (INSA)-Université de Toulouse (UT)-Institut National des Sciences Appliquées (INSA)-Centre National de la Recherche Scientifique (CNRS)-Centre National de la Recherche Scientifique (CNRS), SMODD - Systèmes Moléculaires Organisés et Développement Durable (SMODD), Institut National des Sciences Appliquées (INSA)-Université de Toulouse (UT)-Institut National des Sciences Appliquées (INSA)-Centre National de la Recherche Scientifique (CNRS)-Centre National de la Recherche Scientifique (CNRS)-Institut de Chimie de Toulouse (ICT), CNRS, INSERM, University of Toulouse, Toulouse-Tech-Transfer (contract I-15-1424), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre National de la Recherche Scientifique (CNRS)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées, Laboratoire de Biochimie [Purpan], Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse]-Institut Fédératif de Biologie (IFB) - Hôpital Purpan, Hôpital Purpan [Toulouse], CHU Toulouse [Toulouse]-CHU Toulouse [Toulouse]-Hôpital Purpan [Toulouse], CHU Toulouse [Toulouse], Laboratoire de Chimie Biomoléculaires, Substances Naturelles et Réactivité, URAC16, Faculté des Sciences, Semlalia, Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Institut de Chimie de Toulouse (ICT-FR 2599), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS)-Institut de Chimie du CNRS (INC)-Institut de Chimie de Toulouse (ICT-FR 2599), Université Fédérale Toulouse Midi-Pyrénées-Institut de Chimie du CNRS (INC)-Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD), Centre de Physiopathologie Toulouse Purpan (ex IFR 30 et IFR 150) (CPTP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut de Recherche pour le Développement (IRD)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Centre National de la Recherche Scientifique (CNRS)-Centre National de la Recherche Scientifique (CNRS), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut de Chimie de Toulouse (ICT-FR 2599), Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS)-Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Institut de Recherche pour le Développement (IRD)-Centre National de la Recherche Scientifique (CNRS), Institut de Chimie de Toulouse (ICT-FR 2599), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Institut de Recherche pour le Développement (IRD)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS), FRUCHON, Séverine
المصدر: Biomolecules
Biomolecules, 2019, 9 (9), pp.475. ⟨10.3390/biom9090475⟩
Biomolecules, MDPI, 2019, 9 (9), pp.475. ⟨10.3390/biom9090475⟩
Volume 9
Issue 9
Biomolecules, Vol 9, Iss 9, p 475 (2019)مصطلحات موضوعية: MESH: Dendrimers / adverse effects, genetic structures, [SDV]Life Sciences [q-bio], lcsh:QR1-502, Anti-Inflammatory Agents, Mutagen, 02 engineering and technology, Rabbit, Pharmacology, medicine.disease_cause, 01 natural sciences, Biochemistry, lcsh:Microbiology, MESH: Anti-Inflammatory Agents / chemistry, Mice, Biodistribution, Tissue Distribution, MESH: Animals, ComputingMilieux_MISCELLANEOUS, Chemistry, Drug candidate, Preclinical development, 021001 nanoscience & nanotechnology, MESH: Dendrimers / pharmacokinetics, 3. Good health, [SDV] Life Sciences [q-bio], MESH: Hydrazones / chemistry, Female, Safety, 0210 nano-technology, Dendrimers, MESH: Rats, medicine.drug_class, MESH: Anti-Inflammatory Agents / adverse effects, 010402 general chemistry, Rodents, Article, Anti-inflammatory, Azabisphosphonate, Immune system, MESH: Anti-Inflammatory Agents / pharmacokinetics, Dendrimer, medicine, Animals, [CHIM]Chemical Sciences, MESH: Tissue Distribution, MESH: Dendrimers / chemistry, Molecular Biology, MESH: Mice, MESH: Safety, Hydrazones, In vitro, Rats, 0104 chemical sciences, MESH: Female, Genotoxicity
وصف الملف: application/pdf
-
5
المساهمون: Doctoral Programme in Drug Research, Division of Pharmacology and Pharmacotherapy, Helsinki One Health (HOH), Drug Research Program, Clinical Pharmacy Group, Doctoral Programme in Population Health, HUS Pharmacy
المصدر: Pharmacy Practice (Granada) v.17 n.4 2019
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Pharmacy Practice
Pharmacy Practice (Granada), Volume: 17, Issue: 4, Article number: 1583, Published: 20 APR 2020
Pharmacy Practice, Vol 17, Iss 4, p 1583 (2019)مصطلحات موضوعية: lcsh:RS1-441, RECONCILIATION, Pharmaceutical Science, mesh:Health Plan Implementation, Pharmacy, 030226 pharmacology & pharmacy, mesh:Europe, 0302 clinical medicine, Patient Admission, Surveys and Questionnaires, Electronic Health Records, mesh:Safety Management, mesh:Pharmacy Service Hospital, media_common, Original Research, Hospitals, Patient Discharge, 3. Good health, Europe, Work (electrical), 317 Pharmacy, Patient Safety, Pharmacy Service, Hospital, Medication list, Safety Management, mesh:Electronic Health Records, media_common.quotation_subject, pharmacy service hospital, mesh:Patient Safety, mesh:European Union, lcsh:Pharmacy and materia medica, 03 medical and health sciences, Patient safety, Medication Reconciliation, Nursing, mesh:Patient Admission, QUALITY, media_common.cataloged_instance, Quality (business), Safety culture, European Union, European union, mesh:Patient Discharge, mesh:Hospitals, mesh:Delivery of Health Care, lcsh:RM1-950, mesh:Medication Reconciliation, Health Plan Implementation, CARE, Clinical pharmacy, lcsh:Therapeutics. Pharmacology, Content analysis, mesh:Surveys and Questionnaires, Business, Delivery of Health Care, Pharmacy Service Hospital
وصف الملف: text/html
-
6
المؤلفون: Pradalier, Fanny
المساهمون: Thèses d'exercice et mémoires - UFR de Médecine Montpellier-Nîmes, Université de Montpellier (UM), Claire Jourdan
المصدر: Médecine humaine et pathologie. 2018
مصطلحات موضوعية: Rééducation précoce, MESH: Safety, Neuro-ICU, MESH: Sécurité, Early rehabilitation, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology, Neuro-réanimation
URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______2592::100dcf63caea6f0e18e517a3cad28ac4
https://dumas.ccsd.cnrs.fr/dumas-03211393/document -
7
المؤلفون: garcin, laure
المساهمون: Université Paris Descartes - Faculté de Médecine (UPD5 Médecine), Université Paris Descartes - Paris 5 (UPD5), Jacques Beltrand
المصدر: Médecine humaine et pathologie. 2017
مصطلحات موضوعية: Efficacité, MESH: Genetic Diseases, Inborn, MESH: Diabetes Mellitus, MESH: Chromosomes, Human, Pair 6, Sulfamides hypoglycémiants, MESH: Safety, Neonatal diabetes, Sécurité, MESH: Efficiency, Diabète monogénique, Chromosome 6, MESH: Sulfanilamides, Ddiabète néonatal, Méta-analyse, MESH: Hypoglycemic Agents, MESH: Meta-Analysis as Topic, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______2592::ff2983f83eb16212f011ea886c6e8a25
https://dumas.ccsd.cnrs.fr/dumas-01814908 -
8
المساهمون: Université de Montréal (UdeM), Institut Armand Frappier (INRS-IAF), Institut National de la Recherche Scientifique [Québec] (INRS)-Réseau International des Instituts Pasteur (RIIP), The QUALITY cohort is funded by the Canadian Institutes of Health Research (#OHF-69442, #NMD-94067, #MOP-97853, #MOP-119512), the Heart and Stroke Foundation of Canada (#PG-040291) and Fonds de la recherche en santé du Québec
المصدر: Journal of Urban Health
Journal of Urban Health, Springer Verlag (Germany), 2015, 92 (1), pp.10-23. ⟨10.1007/s11524-014-9917-0⟩مصطلحات موضوعية: Male, Parents, Socioecological model, Health Knowledge, Attitudes, Practice, Health (social science), MESH: Asthma, MESH: Quebec, [SDV]Life Sciences [q-bio], MESH: Health Knowledge, Attitudes, Practice, Child Behavior, Poison control, MESH: Comorbidity, Comorbidity, Social Environment, Suicide prevention, Occupational safety and health, Developmental psychology, Residence Characteristics, MESH: Child, MESH: Residence Characteristics, Parent-Child Relations, Child, MESH: Social Environment, Quebec, Human factors and ergonomics, MESH: Stress, Psychological, Female, Safety, Social psychology, MESH: Socioeconomic Factors, MESH: Parent-Child Relations, medicine.medical_specialty, Article, Structural equation modeling, Injury prevention, medicine, Humans, [SDV.EE.SANT]Life Sciences [q-bio]/Ecology, environment/Health, MESH: Parents, MESH: Humans, Neighborhood, business.industry, Public health, MESH: Safety, Public Health, Environmental and Occupational Health, Social environment, Asthma, MESH: Male, Québec, Urban Studies, Socioeconomic Factors, Parent, MESH: Child Behavior, business, MESH: Female, Stress, Psychological
-
9
المساهمون: Université de Montréal [Montréal], CHU Sainte Justine [Montréal], Institut Armand Frappier (INRS-IAF), Institut National de la Recherche Scientifique [Québec] (INRS) - Réseau International des Instituts Pasteur - Institut Armand Frappier, Concordia University [Montreal, Canada], Centre de recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Institut de recherche en santé publique de l'université de Montréal (IRSPUM), International Network for Research on Inequalities in Child Health (INRICH), Centre de Recherche Léa-Roback sur les Inégalités Sociales de Santé de Montréal, This study was funded by the Canadian Institutes of Health Research (CIHR) Grant Number 00309MOP-123079. Data were collected by the Institut de la Statistique du Québec, Direction Sante Québec. The IRSPUM and CRCHUM receivedinfrastructure funding from the Fonds de la Recherche en Santé du Québec. CCL is funded by a Fonds de Recherche du Québec -Sociéte et Culture fellowship. TB is supported by a FRQS Junior 2 Research Scholar award. YK holds a Young Investigator Award from Fonds de Recherche du Québec – Santéand a CIHR Applied Public Health Chair on Urban Interventions and Population Health. MTT was funded by a young investigator fellowship from the IRSPUM and was the recipient of a Young Investigator Award from the National Alliance for Research on Schizophrenia and Depression, the former name of the Brain & Behavior Research Foundation, at the time of the contribution. These funding agencies were not involved in the studydesign, data analyses, data interpretation or manuscript writing and submission processes. These findings were presented at the 81st conference of the Association Francophone pour le Savoir (ACFAS) and the 5th Annual Workshop of the International Network for Research on Inequalities in Child Health (INRICH)., Université de Montréal (UdeM), Institut National de la Recherche Scientifique [Québec] (INRS)-Réseau International des Instituts Pasteur (RIIP), Concordia University [Montreal], Centre Hospitalier de l'Université de Montréal (CHUM)
المصدر: Journal of Youth and Adolescence
Journal of Youth and Adolescence, Springer Verlag, 2015, 44 (6), pp.1194-207. <10.1007/s10964-014-0214-8>
Journal of Youth and Adolescence, Springer Verlag, 2015, 44 (6), pp.1194-207. ⟨10.1007/s10964-014-0214-8⟩مصطلحات موضوعية: School, Male, Longitudinal study, Youth, MESH: Quebec, MESH: Poverty, [SDV]Life Sciences [q-bio], Poverty trajectory, Poison control, Social Environment, Occupational safety and health, [SHS]Humanities and Social Sciences, Developmental psychology, [SHS.ENVIR] Humanities and Social Sciences/Environmental studies, Residence Characteristics, MESH: Child, Developmental and Educational Psychology, MESH: Residence Characteristics, Longitudinal Studies, MESH: Longitudinal Studies, Child, media_common, MESH: Social Environment, Family Characteristics, education.field_of_study, Quebec, MESH: Follow-Up Studies, MESH: Infant, [SDV] Life Sciences [q-bio], Feeling, Child, Preschool, Female, [SHS] Humanities and Social Sciences, Safety, Psychology, Attitude to Health, Adolescent, Social Psychology, media_common.quotation_subject, education, Population, MESH: Attitude to Health, Education, Environmental health, MESH: Family Characteristics, [SDV.EE.SANT] Life Sciences [q-bio]/Ecology, environment/Health, Humans, Poverty, MESH: Adolescent, [SDV.EE.SANT]Life Sciences [q-bio]/Ecology, environment/Health, [SHS.ANTHRO-SE] Humanities and Social Sciences/Social Anthropology and ethnology, MESH: Humans, Neighborhood, Latent growth modeling, MESH: Safety, MESH: Child, Preschool, Infant, [SHS.ANTHRO-SE]Humanities and Social Sciences/Social Anthropology and ethnology, Residential, MESH: Male, MESH: Adolescent Behavior, Disadvantaged, Adolescent Behavior, [SHS.ENVIR]Humanities and Social Sciences/Environmental studies, MESH: Female, Social Sciences (miscellaneous), Follow-Up Studies
-
10
المؤلفون: C. Studer, W. Sankou, Alfred Penfornis, Marc Puyraveau, Emmanuel Samain, A. Cordier, Joseph-Philippe Etievent, Sebastien Pili-Floury
المساهمون: Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), Service de Diabétologie - Endocrinologie [CHRU Besançon], Marqueurs pronostiques et facteurs de régulations des pathologies cardiaques et vasculaires - UFC ( EA 3920) (PCVP / CARDIO), Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC)-Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), Hôpital Jean Minjoz, Centre Hospitalier Régional Universitaire [Besançon] ( CHRU Besançon ), Service de diabétologie - endocrinologie, Centre Hospitalier Régional Universitaire [Besançon] ( CHRU Besançon ) -Hôpital Jean Minjoz, Marqueurs pronostiques et facteurs de régulations des pathologies cardiaques et vasculaires - UFC ( PCVP / CARDIO ), Université Bourgogne Franche-Comté ( UBFC ) -Université de Franche-Comté ( UFC ) -Centre Hospitalier Régional Universitaire [Besançon] ( CHRU Besançon )
المصدر: Diabetes and Metabolism
Diabetes and Metabolism, Elsevier Masson, 2010, 36 (1), pp.71-8. ⟨10.1016/j.diabet.2009.05.008⟩
Diabetes and Metabolism, Elsevier Masson, 2010, 36 (1), pp.71-8. 〈10.1016/j.diabet.2009.05.008〉مصطلحات موضوعية: Blood Glucose, Male, MESH: Hypoglycemia, MESH : Insulin, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, MESH : Aged, Aorta, Thoracic, 030204 cardiovascular system & hematology, law.invention, Intraoperative Period, 0302 clinical medicine, Endocrinology, MESH: Postoperative Period, law, Insulin, MESH : Female, Postoperative Period, 030212 general & internal medicine, Coronary Artery Bypass, Infusions, Intravenous, Prospective cohort study, MESH: Aged, MESH: Middle Aged, MESH: Cardiac Surgical Procedures, MESH : Vascular Surgical Procedures, MESH : Infusions, Intravenous, General Medicine, [ SDV.MHEP.CSC ] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Middle Aged, Intensive care unit, 3. Good health, Cardiac surgery, MESH : Intraoperative Period, Female, Safety, Vascular Surgical Procedures, medicine.medical_specialty, MESH : Male, MESH: Aorta, Thoracic, MESH : Drug Administration Schedule, MESH: Monitoring, Intraoperative, MESH: Insulin, MESH: Drug Administration Schedule, Hypoglycemia, MESH : Cardiac Surgical Procedures, Drug Administration Schedule, 03 medical and health sciences, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, MESH: Hypoglycemic Agents, Monitoring, Intraoperative, Diabetes mellitus, Internal Medicine, medicine, Humans, Hypoglycemic Agents, MESH : Middle Aged, MESH : Safety, Cardiac Surgical Procedures, MESH: Infusions, Intravenous, MESH: Vascular Surgical Procedures, Pancreatic hormone, MESH : Aorta, Thoracic, Aged, MESH : Postoperative Period, MESH: Intraoperative Period, MESH: Humans, MESH : Hypoglycemia, business.industry, MESH: Coronary Artery Bypass, MESH : Humans, MESH: Safety, Perioperative, MESH : Blood Glucose, medicine.disease, MESH : Hypoglycemic Agents, MESH : Coronary Artery Bypass, MESH: Male, Surgery, Hyperglycemia, MESH : Hyperglycemia, MESH: Blood Glucose, MESH : Monitoring, Intraoperative, MESH: Hyperglycemia, business, MESH: Female
Find this article in full text from Springer Verlag. 
Full Text via ClinicalKey